Similarly, fatal autoimmune diseases develop in individuals with mutation of CD25, whereas individuals with heterologous mutations of CTLA-4, including CTLA-4 haploinsufficiency, may develop autoimmune diseases of different spectrums [5,6,7]. Here, IL2RA is linked to autoimmune disease.